BIOCARTIS GR. 144A/REG SBIOCARTIS GR. 144A/REG SBIOCARTIS GR. 144A/REG S

BIOCARTIS GR. 144A/REG S

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪27.24 M‬EUR
‪83.36 M‬
Beta (1Y)
0.00

About BIOCARTIS


CEO
John Roger Moody
Headquarters
Mechelen
Founded
2014
ISIN
BE0974281132
FIGI
BBG008LXWQX7
Biocartis Group NV engages in the development of personalized medicine for patients around the world. It also focuses on developing and commercializing oncology tests. The company was founded by Philippe Renaud, Nader Donzel, and Rudi Pauwels in July 2007 and is headquartered in Mechelen, Belgium.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BIOCARTIS GR. 144A/REG S stocks are traded under the ticker 8XB.
8XB reached its all-time high on Feb 1, 2018 with the price of 12.8574 EUR, and its all-time low was 0.2566 EUR and was reached on Sep 22, 2023. View more price dynamics on 8XB chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track BIOCARTIS GR. 144A/REG S financials in yearly and quarterly reports right on TradingView.
BIOCARTIS GR. 144A/REG S is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
No, 8XB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 8XB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCARTIS GR. 144A/REG S stock right from TradingView charts — choose your broker and connect to your account.